SHARE:  
Join Our Email List
Join Our Community:
Volume 03 Issue 03
January 17, 2022
Because life depends on us™
BSMA Clearing House
for latest news and information
...at a glance
ORGANIZATION NEWS!
















EXECUTIVE NEWS!










The Editorial
Life sciences companies continue to grapple with supply chain challenges

Kinaxis Blog (01/13/2022)

The PPE shortage has long been resolved, but the same basic scenario has played out dozens of times since in the life sciences industry. In the early days of the pandemic, production shutdowns in plants that produce active pharmaceutical ingredients (APIs) and drug substances (DS) resulted in some initial delays, but manufacturers were able to put measures in place to prevent this from being an ongoing issue. Demand spikes throughout the pandemic, however, have worsened a decade-long shortage of many life-saving drugs, including tocilizumab, a targeted anti-inflammatory drug used for chemotherapy and the treatment of COVID-19 patients, inhalers used to treat asthma, as well as various blood pressure medications. Pharmacists have even experienced a shortage of the vials used to put medication in. When faced with these shortages, hospitals and pharmacies have to do whatever they can to make sure those most in need get the right drugs.
Manufacturers of high-tech medical devices used to diagnose, treat and protect patients are also dealing with a variety of ongoing supply chain issues. A global semiconductor shortage, for example, is disrupting the production of everything from sleep apnea machines and ventilators to defibrillators, implantable pacemakers, blood glucose monitors and portable ultrasound devices. Because the greatest demand is for second- and third-generation chips, the medtech industry is in direct competition with the automotive, industrial and consumer industries, a scenario which is further exacerbating the situation.
To make matters worse, the medtech industry is also dealing with the fallout from a shortage of resin, a raw material used in the production of numerous medical devices, including stents and grafts, heart valves, bioelectrodes and biosensors, drug delivery systems, MRI machines, etc.
Whether it’s a shortage of chips or resin used to deliver critical medical devices, or a delay in the delivery of the ingredients used to manufacture life-saving drugs, these supply chain issues place the

INNOVATIONS!
INFRASTRACTURE
CHALLENGES & SOLUTIONS!



















UPCOMING EVENTS:

~~~~~~~
SAVE THESE DATES!!!

Due to the Omicron Virus,
we have postponed our event to June.
Please stay tune.

2 DAY In-person Conference:
Wednesday: CLINICAL WORKSHOP
Thursday: BSMA SPRING CONFERENCE

LOCATION: Crowne Plaza Hotel, Foster City, California
Details to follow, Keep posted
Editor:
Devendra Mishra
Executive Director & Co-Founder
BSMA
+1-818-224-1552
Editor:
Dotti Yells
VP, Marketing Technology
BSMA